tiprankstipranks
Trending News
More News >
Harel Insurance Investments & Financial Services Ltd. (IL:HARL)
:HARL

Harel (HARL) AI Stock Analysis

Compare
1 Followers

Top Page

IL

Harel

(OTC:HARL)

Rating:73Outperform
Price Target:
10,514.00
▲(13.15%Upside)
The overall stock score of 73 reflects Harel's strong technical indicators and attractive valuation amidst financial performance challenges. The stock benefits from bullish momentum and a good dividend yield, offset by high leverage and cash flow issues.

Harel (HARL) vs. iShares MSCI Israel ETF (EIS)

Harel Business Overview & Revenue Model

Company DescriptionHarel (HARL) is a diversified company operating within distinct sectors, primarily focusing on insurance and financial services. The company offers a range of products and services including life insurance, non-life insurance, and pension fund management. Harel is known for its robust insurance solutions that cater to both individual and corporate clients, and its commitment to providing financial security and risk management.
How the Company Makes MoneyHarel makes money through a diversified revenue model primarily driven by premium collections from its insurance products, including life and non-life insurance policies. The company also generates revenue from managing pension funds, where it earns fees based on assets under management. Additionally, Harel invests its collected premiums in various financial instruments, which contributes to its investment income. Key partnerships with financial institutions and strategic investments in technology further enhance its service offerings and expand its client base, contributing to its overall earnings.

Harel Financial Statement Overview

Summary
Harel's financial performance is characterized by strong revenue growth and improving profitability, as seen in the income statement. However, the high leverage on the balance sheet and negative cash flow present significant risks. The company needs to focus on improving operational efficiencies and managing its leverage to sustain growth and mitigate these risks.
Income Statement
74
Positive
Harel demonstrates strong revenue growth, with a recent TTM revenue of $27.16 billion, up from $24.86 billion in the previous year, marking a growth rate of 11.21%. The gross profit margin is consistently high at 100%, indicating strong pricing power or cost management. Net profit margin improved to 3.48% from 1.95%, reflecting enhanced profitability. However, EBIT and EBITDA margins are relatively modest at 4.99% and 9.03%, respectively, suggesting room for operational efficiency improvements.
Balance Sheet
62
Positive
The balance sheet shows a debt-to-equity ratio of 2.03, indicating significant leverage but typical for a financial conglomerate. Return on equity is healthy at 10.38%, showcasing effective use of equity capital. The equity ratio stands at 5.75%, suggesting a heavy reliance on liabilities which could pose risks in volatile markets. Overall, while there is solid equity growth, the high leverage could be a concern.
Cash Flow
55
Neutral
Harel's cash flow situation has deteriorated, with a negative free cash flow of -$3.53 billion as opposed to a positive $3.02 billion previously. The operating cash flow to net income ratio is negative, highlighting operational cash flow challenges. Despite negative free cash flow, there is potential for improvement if cost management and operational efficiencies are addressed.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue27.16B24.86B12.69B27.48B18.72B
Gross Profit27.16B24.86B12.69B27.48B18.72B
EBITDA2.45B1.53B2.05B2.31B1.18B
Net Income946.00M485.00M906.00M1.21B724.00M
Balance Sheet
Total Assets158.66B144.81B135.27B137.67B119.75B
Cash, Cash Equivalents and Short-Term Investments25.53B26.50B24.89B26.25B21.78B
Total Debt18.50B10.95B7.28B7.14B6.03B
Total Liabilities149.46B135.85B126.88B128.78B111.99B
Stockholders Equity9.12B8.89B8.34B8.86B7.74B
Cash Flow
Free Cash Flow-3.52B3.02B1.60B1.13B1.07B
Operating Cash Flow-3.06B3.47B1.98B1.49B1.41B
Investing Cash Flow-1.02B-511.00M-371.00M-632.00M-203.00M
Financing Cash Flow1.45B1.01B-1.01B581.00M35.00M

Harel Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9292.00
Price Trends
50DMA
6919.88
Positive
100DMA
6490.04
Positive
200DMA
5408.56
Positive
Market Momentum
MACD
688.50
Negative
RSI
82.88
Negative
STOCH
94.39
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HARL, the sentiment is Positive. The current price of 9292 is above the 20-day moving average (MA) of 7913.25, above the 50-day MA of 6919.88, and above the 200-day MA of 5408.56, indicating a bullish trend. The MACD of 688.50 indicates Negative momentum. The RSI at 82.88 is Negative, neither overbought nor oversold. The STOCH value of 94.39 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:HARL.

Harel Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
24.07B11.20
3.75%-11.69%105.99%
73
Outperform
$19.44B15.7912.96%5.14%-10.79%67.20%
72
Outperform
16.63B13.53
3.63%-2.35%80.26%
67
Neutral
3.24B10.88
6.79%25.90%68.30%
67
Neutral
10.12B13.20
0.61%-16.50%29.61%
64
Neutral
$6.62B10.866.59%5.05%24.65%0.99%
63
Neutral
12.35B11.34
1.69%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:HARL
Harel
9,292.00
6,294.09
209.95%
IL:MGDL
Migdal Insur.
996.40
570.26
133.82%
IL:MMHD
Menora Miv Hld
26,670.00
18,110.44
211.58%
IL:CLIS
Clal Insurance
16,150.00
10,885.07
206.75%
IL:IDIN
Idi Insur
22,270.00
13,443.20
152.30%
IL:PHOE
Phoenix
9,850.00
6,520.31
195.82%

Harel Corporate Events

Harel Insurance Company Shows Resilience Amid Solvency Ratio Decline
Feb 16, 2025

Harel Insurance Company is experiencing a decrease in solvency ratio, projected to reach 167% by the end of 2024 due to financial market changes and regulatory adjustments. Despite this, the company maintains strong capital adequacy and stable profitability from insurance activities, underscoring its resilience and commitment to market position amidst global financial challenges.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 30, 2025